AYTU BIOPHARMA, INC Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
AYTU BIOPHARMA, INC (AYTU) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $18.37 per share for the 12-month period ending 2023-06-30, per its 10-K filed 2023-10-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2023-10-12
- AYTU BIOPHARMA, INC share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2023 was $18.37, a 10.60% increase from fiscal 2022.
- AYTU BIOPHARMA, INC share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2022 was $16.61, a 14.39% increase from fiscal 2021.
- AYTU BIOPHARMA, INC share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2021 was $14.52.
- AYTU BIOPHARMA, INC share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2019 was $325.73, a 0.07% decline from fiscal 2018.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|
| 2023-06-30 | $18.37 10-K · filed 2023-10-12 |
| 2022-06-30 | $16.61 10-K · filed 2022-09-27 |
| 2021-06-30 | $14.52 10-K · filed 2021-09-28 |
| 2019-06-30 | $325.73 10-K · filed 2019-09-26 |
| 2018-06-30 | $325.97 10-K · filed 2018-09-06 |
| 2017-06-30 | $16.31 10-K · filed 2017-08-31 |
| 2016-06-30 | $18.01 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |